Literature DB >> 25353353

Interaction of Bordetella pertussis filamentous hemagglutinin with human TLR2: identification of the TLR2-binding domain.

Hossein Asgarian-Omran1, Ali Akbar Amirzargar, Sacha Zeerleder, Marzieh Mahdavi, Gerard van Mierlo, Shabnam Solati, Mahmood Jeddi-Tehrani, Hodjatallah Rabbani, Leucien Aarden, Fazel Shokri.   

Abstract

Filamentous hemagglutinin (FHA) is a major adhesion and virulence factor of Bordetella pertussis and also a main component of acellular pertussis vaccines. Interaction of FHA with different receptors on human epithelial and immune cells facilitates entrance and colonization of bacteria as well as immunomodulation of the host immune response. Three overlapping segments of the FHA gene were cloned in a prokaryotic expression vector and the recombinant proteins were purified. These recombinant fragments along with the native FHA protein were employed to assess their potential Toll-like receptor (TLR) stimulatory effects and to localize the TLR binding region. TLR stimulation was monitored by applying HEK293-Blue cell lines cotransfected with TLR2, 4, or 5 and a NF-κB reporter gene. Culture supernatants were checked for secretion of the reporter gene product and IL-8 as indicators of TLR stimulation. Native FHA was found to strongly stimulate TLR2, but not TLR4 or TLR5 transfected cells. Among recombinant FHA fragments only the fragment spanning amino acid residues 1544-1917 was able to exhibit the TLR2 stimulating property of FHA. Interaction of FHA with TLR2 suggests its involvement in induction of the innate immune system against Bordetella pertussis. The TLR2-binding domain of FHA may contribute to immunoprotection against pertussis infection.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Bordetella pertussis; TLR2; Toll-like receptor; filamentous hemagglutinin; innate immunity

Mesh:

Substances:

Year:  2014        PMID: 25353353     DOI: 10.1111/apm.12332

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

Review 1.  Bordetella pertussis: new concepts in pathogenesis and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

2.  Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.

Authors:  Michael R Weigand; Lucia C Pawloski; Yanhui Peng; Hong Ju; Mark Burroughs; Pamela K Cassiday; Jamie K Davis; Marina DuVall; Taccara Johnson; Phalasy Juieng; Kristen Knipe; Vladimir N Loparev; Marsenia H Mathis; Lori A Rowe; Mili Sheth; Margaret M Williams; M Lucia Tondella
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Emerging Bordetella pertussis Strains Induce Enhanced Signaling of Human Pattern Recognition Receptors TLR2, NOD2 and Secretion of IL-10 by Dendritic Cells.

Authors:  Elise S Hovingh; Marjolein van Gent; Hendrik-Jan Hamstra; Marc Demkes; Frits R Mooi; Elena Pinelli
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

Review 4.  Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.

Authors:  Sudeep Kumar; Raju Sunagar; Edmund Gosselin
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

Review 5.  Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections.

Authors:  Monica C Gestal; Hannah M Johnson; Eric T Harvill
Journal:  Front Immunol       Date:  2019-12-13       Impact factor: 7.561

6.  Anti-FIM and Anti-FHA Antibodies Inhibit Bordetella pertussis Growth and Reduce Epithelial Cell Inflammation Through Bacterial Aggregation.

Authors:  Issaka Yougbare; Adam McTague; Liwei He; Christopher H Choy; Jin Su; Beata Gajewska; Ali Azizi
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

Review 7.  Precision Vaccine Development: Cues From Natural Immunity.

Authors:  Soumik Barman; Dheeraj Soni; Byron Brook; Etsuro Nanishi; David J Dowling
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

8.  Enhancement of immune response against Bordetella spp. by disrupting immunomodulation.

Authors:  Monica C Gestal; Laura K Howard; Kalyan Dewan; Hannah M Johnson; Mariette Barbier; Clare Bryant; Illiassou Hamidou Soumana; Israel Rivera; Bodo Linz; Uriel Blas-Machado; Eric T Harvill
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.